Last updated 2026-06-18
Total raised
—
Stage
Pre-Funding
Founded
2008
Headcount
6
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences
About
BrainWatch is developing imaging agents for MRI scanning. These imaging agents are used as biomarkers for specific diseases, in particular Alzheimer's disease and breast cancer. BrainWatch's biomarkers will notbe radioactive and will aim to have lower procedure costs and better diagnostic accuracy.
Q&A
- What is BrainWatch's primary focus?
- BrainWatch is developing molecular imaging agents for MRI scanning, specifically for use as biomarkers for diseases like Alzheimer's disease and breast cancer.
- What are the key advantages of BrainWatch's imaging agents?
- BrainWatch's biomarkers are designed to be non-radioactive, aiming for lower procedure costs and improved diagnostic accuracy.
- When was BrainWatch founded?
- BrainWatch was founded in January 2008.
- Where is BrainWatch headquartered?
- BrainWatch is headquartered in Tel Aviv-Yafo, Center District, Israel.
- What is BrainWatch's current operational status?
- BrainWatch is currently inactive, with its status changed in August 2017.
- How many employees does BrainWatch have?
- BrainWatch has 1-10 employees.
- In which sector does BrainWatch primarily operate?
- BrainWatch's primary sector is Health Tech & Life Sciences.
- What is BrainWatch's current funding stage?
- BrainWatch is in the Pre-Funding stage.
Team · 1
Founder · Founder & CEO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Target customers
Healthcare & Life SciencesHealthcareProviders
Tags
mrimedical-devicescancerdiagnosticsbiomarkersalzheimers-disease
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2008-1 |
|---|---|
| Employees (exact) | 6 |
| Status reason | Non Active, Aug 2017 |